New eczema drug TRB-061 enters first human trials
Disease control
Recruiting now
This early-stage trial tests a new drug called TRB-061 in healthy adults and people with moderate-to-severe atopic dermatitis (eczema). The study checks for safety, side effects, and how the drug moves through the body. Participants receive either TRB-061 or a placebo as injectio…
Phase: PHASE1 • Sponsor: TRex Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC